Irbesartan Tablet
Product Images NDC 72603-670

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 72603-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

789 (Irbesartan 150mg 90s Daman)

789 (Irbesartan 150mg 90s Daman)
Label for Irbesartan Tablets, USP 150 mg, oral tablet by NorthStar Rx LLC. The label states the quantity as 90 tablets and includes storage instructions at 20° to 25°C with permitted excursions to 15° to 30°C. It shows the NDC 72603-671-01 and manufacturing information for Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

789 (Irbesartan 150mg 90s Pithampur)

789 (Irbesartan 150mg 90s Pithampur)
Label for Irbesartan Tablets, USP 150 mg oral tablets by NorthStar Rx LLC. The label shows a package size of 90 tablets and includes storage instructions at controlled room temperature. The product is manufactured by Macleods Pharmaceuticals Ltd. in India. The NDC is partially visible.*
FDA Label Image

789 (Irbesartan 300mg 30s Daman)

789 (Irbesartan 300mg 30s Daman)
Packaging label of Irbesartan Tablets, USP 300 mg oral tablets by NorthStar Rx LLC. The label displays the NDC number 72603-672-01 and indicates a package size of 30 tablets. Manufacturer details include Macleods Pharmaceuticals Ltd., India. Storage instructions specify 20° to 25°C with allowable excursions.*
FDA Label Image

789 (Irbesartan 300mg 30s Pithampur)

789 (Irbesartan 300mg 30s Pithampur)
Label for Irbesartan Tablets, USP 300 mg oral tablets in a 30 tablet package. The label includes NDC 72603-672-01 and indicates prescription use only. It shows storage instructions, manufacturer NorthStar Rx LLC, and manufacturing by Macleods Pharmaceuticals Ltd. in India. Dosage direction advises to see prescribing information.*
FDA Label Image

789 (Irbesartan 300mg 90s Daman)

789 (Irbesartan 300mg 90s Daman)
Label for Irbesartan Tablets, USP 300 mg oral tablets from NorthStar Rx LLC. The label indicates a package containing 90 tablets and includes storage instructions. The manufacturer is Macleods Pharmaceuticals Ltd., India. The label shows NDC 72603-672-02 with a barcode and dosage reference to prescribing information.*
FDA Label Image

789 (Irbesartan 300mg 90s Pithampur)

789 (Irbesartan 300mg 90s Pithampur)
Label for Irbesartan Tablets USP 300 mg oral tablets, containing 90 tablets per bottle. The label includes storage instructions, prescribing information reference, and indicates manufacturing by Macleods Pharmaceuticals Ltd for NorthStar Rx LLC. The product is identified as prescription-only and manufactured in India.*
FDA Label Image

789 (Irbesartan 75mg 90s Daman)

789 (Irbesartan 75mg 90s Daman)
Label for Irbesartan Tablets, USP 75 mg oral tablets by NorthStar Rx LLC. The label shows a 90-tablet count and includes storage instructions and barcode. Manufactured by Macleods Pharmaceuticals Ltd., India. The NDC is 72603-670-01.*
FDA Label Image

789 (Irbesartan 75mg 90s Pithampur)

789 (Irbesartan 75mg 90s Pithampur)
Label for Irbesartan Tablets, USP 75 mg oral tablets by NorthStar RxLLC. The package contains 90 tablets. Storage instructions and manufacturing details, including production by Macleods Pharmaceuticals Ltd. in India, are included. The label features the NDC number 72603-670-01 and barcodes.*
FDA Label Image

Fig-1-2 (Irbesartan Figure 1 2)

Fig-1-2 (Irbesartan Figure 1 2)
Two integrated analysis plots show placebo-subtracted reductions in trough systolic (SeSBP) and diastolic (SeDBP) blood pressures relative to irbesartan dose (mg/day). Each graph presents dose on the x-axis and blood pressure reduction in mmHg on the y-axis, with scatter points and smooth curves indicating dose-response relationships.*
FDA Label Image

Fig-3 (Irbesartan Figure 3)

Fig-3 (Irbesartan Figure 3)
Kaplan-Meier estimates chart showing cumulative event rate percentages over months of follow-up for primary endpoints, comparing Irbesartan, Amlodipine, and placebo groups. The chart includes lines for each treatment and statistical values for Irbesartan versus placebo and Amlodipine.*
FDA Label Image

Irbesartan (Irbesartan)

Irbesartan (Irbesartan)
Chemical structure diagram of Irbesartan showing its molecular composition with labeled ring structures and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.